| Rivopharm SA - Doxepin Rivopharm 50 mg, capsule rigide | | 69433 | | 02 | | Doxepin Rivopharm 50 mg | | capsule rigide | | N06AA12 | | Doxepin | | 23.07.2024 | | |
| | Composition | | doxepinum 50 mg ut doxepini hydrochloridum, lactosum monohydricum 175.686 mg, maydis amylum, magnesii stearas, natrii laurilsulfas, gelatina, E 171, E 127, E 131, pro capsula corresp. natrium 0.205 mg. | | Packungsbestandteile | | capsule rigide | | | | | | Principe actif | Concentr. |
|---|
| Doxepin | 50 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| E 127 | | color. | | E 131 | | color. | | E 171 | | color. | | Gelatina | | | | Lactose Monohydrate | 175.686 mg | | | Magnesii Stearas | | | | Maydis Amylum | | | | Natrii Laurilsulfas | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | 28 | DDP | DDP | B | | Non | | 004 | 98 | DDP | DDP | B | | Non |
|
|
